Celecoxib, meloxicam, and paracetamol provide pain relief in Kashin-Beck disease patients .
Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck disease (KBD) patients
Int Orthop. 2011 Sep;35(9):1409-14. doi: 10.1007/s00264-010-1062-0. Epub 2010 Jun 13168 elderly patients were randomized to examine the efficacy of celecoxib, meloxicam, and paracetamol in treating symptoms of late Kashin-Beck disease. Patients received a six week course of celecoxib 200 mg once daily, meloxicam 7.5 mg once daily or paracetamol 300 mg three times daily. Results revealed that all three treatments were effective in relieving pain throughout the course of 6 weeks; however, none of the drugs improved overall physical function.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
